Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Published Online
on August 23, 2007

Stroke. 2007
Published online before print August 23, 2007, doi: 10.1161/STROKEAHA.107.484162
A more recent version of this article appeared on October 1, 2007
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
38/10/2847    most recent
STROKEAHA.107.484162v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kölsch, H.
Right arrow Articles by Thal, D. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kölsch, H.
Right arrow Articles by Thal, D. R.
Related Collections
Right arrow Genetics of cardiovascular disease
Right arrow Mechanism of atherosclerosis/growth factors
Right arrow Pathophysiology
Right arrow Cell biology/structural biology
Right arrow Brain Circulation and Metabolism

Submitted on February 1, 2007
Revised on February 23, 2007
Accepted on March 20, 2007

Association of the Glutathione S-transferase Omega-1 Ala140Asp Polymorphism With Cerebrovascular Atherosclerosis and Plaque-Associated Interleukin-1{alpha} Expression

Heike Kölsch PhD; Sergey Larionov MD; Oliver Dedeck; Mario Orantes MD; Gerd Birkenmeier MD; W. Sue T. Griffin PhD; and Dietmar Rudolf Thal MD*

From the Departments of Psychiatry (H.K.), and Neuropathology (S.L., O.D., D.R.T.), University of Bonn, Bonn, Germany; the Department of Pathology (M.O.), Municipal Hospital Offenbach am Main, Offenbach am Main, Germany; the Department of Biochemistry (G.B.), University of Leipzig, Leipzig, Germany; and the Donald W. Reynolds Center on Aging (W.S.T.G.), UAMS, Geriatric Research Education and Clinical Center, Veterans' Affairs Medical Center, Little Rock, Ark.

* To whom correspondence should be addressed. E-mail: Didithal{at}aol.com.

Background and Purpose—Glutathione S-transferase omega-1 is a multifunctional enzyme. The Asp/Asp genotype of the Ala140Asp polymorphism of the GSTO1 gene has been alleged to increase the risk of vascular dementia. The objective of this study is to address the question of whether common vessel disorders known to cause vascular dementia are modified in their severity by this polymorphism.

Methods—The severity and expansion of atherosclerosis in the circle of Willis vessels, cerebral small vessel disease, and cerebral amyloid angiopathy were studied in a sample of 79 autopsy cases. Genotyping of the GSTO1 Ala140Asp polymorphism as well as immunohistochemistry for glutathione S-transferase omega-1 was performed.

Results—Carriers of the GSTO1 Asp/Asp genotype presented with more severe and widespread atherosclerosis than noncarriers. However, there was no effect on small vessel disease expansion and cerebral amyloid angiopathy severity. Immunohistochemically, we detected interleukin-1{alpha} expressing macrophages in the lipid core of atherosclerosis plaques exhibiting glutathione S-transferase omega-1-positive material. GSTO1 Asp/Asp carriers showed larger areas of atherosclerosis plaques containing interleukin-1{alpha}-positive material than carriers of the GSTO1 Ala-allele.

Conclusions—The GSTO1 Asp/Asp genotype presumably modulates the severity and expansion of atherosclerosis in the circle of Willis. The cellular colocalization of glutathione S-transferase omega-1 and interleukin-1{alpha} suggests a functional interaction between both proteins which in part might explain the function of glutathione S-transferase omega-1 in the pathogenesis of cerebral atherosclerosis.


Key words: atherosclerosis • cerebral arteries • GSTO1-1